Certara USA Inc.
Doing business as Tripos (De)
- UEI
- FS75C834WEF4
- CAGE
- 6UV65
- Primary NAICS
- 511210 Software Publishers
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 511210 Software Publishers Primary
- SAM.gov registration date
- Website
- certara.com
- Founded
- 2008
- Employees
- 1K-5K
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| The center for drug evaluation and research (cder) of the u.s. Food and drug administration (FDA) requires software to… | Food and Drug Administration | $41,184 | |
| Send explorer plus upgrades - warehouse licenses and annual maintenance | Food and Drug Administration | $129,833 | |
| Certara phoenix quantum software licenses | Food and Drug Administration | $32,044 | |
| Software license | National Cancer Institute | $12,525 | |
| IT software phoenix | CDC Pittsburgh | $45,776 |
About Certara USA Inc.
Certara USA Inc., doing business as Tripos (De), is a technology-enabled drug development and drug safety consultancy. They specialize in accelerating medicines to patients through the use of biosimulation, technology, and services. Certara has received numerous federal contract awards to provide software and IT services related to pharmacokinetic modeling and simulation to various agencies within the Department of Health and Human Services, including the Food and Drug Administration (FDA), National Institutes of Health (NIH), and Centers for Disease Control and Prevention (CDC). Specific services provided through federal contracts include licenses for Certara's Phoenix software for pharmacokinetic and pharmacodynamic modeling and simulation, as well as associated implementation, customization, maintenance and support services.
Certara has provided modeling and simulation software and services to the FDA to support regulatory review activities, with contract awards totaling over $500,000. Services span standalone and networked licenses for Phoenix WinNonlin, Phoenix NLME, Phoenix Connect, and Phoenix Quantum, along with custom modeling tools and upgrades to support review of electronic submissions. The NIH has also contracted Certara's modeling software to the tune of over $25,000, to support cancer research and computational modeling for the Clinical Center. Additionally, the CDC has awarded over $45,000 in contracts for Certara's Phoenix modeling software to inform public health decision-making.
Certara has also participated as a subawardee on federal grants from the University of Florida, providing consulting services for physiologically-based pharmacokinetic modeling in support of developing in vitro-in vivo correlations for locally-acting gastrointestinal drug products. Their team has contributed to model-based analysis leveraging clinical data to demonstrate local and systemic bioequivalence.
Quick answers
What is Certara USA Inc.'s UEI?
Certara USA Inc.'s Unique Entity ID (UEI) in SAM.gov is FS75C834WEF4.
What is Certara USA Inc.'s CAGE code?
Certara USA Inc.'s CAGE code is 6UV65.
What is Certara USA Inc.'s primary NAICS code?
Certara USA Inc.'s primary NAICS code is 511210 (Software Publishers).
Is Certara USA Inc. registered in SAM.gov?
Certara USA Inc.'s SAM.gov registration expired on April 13, 2023.
What is Certara USA Inc.'s most recent federal award?
Certara USA Inc.'s most recent federal contract award is The center for drug evaluation and research (cder) of the u.s. Food and drug administration (FDA) requires software to… (75F40122P00489), from Food and Drug Administration, on September 13, 2022.
On GovTribe
See Certara USA Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors